Scout | NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

This grant is intended to support the implementation of clinical trials in the field of musculoskeletal, rheumatic, and skin diseases. It requires a cooperative agreement and is structured in two phases: UG3 for initial implementation and UH3 for full implementation, contingent on meeting specific milestones. Researchers conducting these trials are expected to collaborate closely with the awar…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Program: SBIR

Award

Award Ceiling: $250,000

Funding Amount: $250,000

Dates

Opportunity Released: May 23, 2024

Open for Submission: May 23, 2024

Submission Deadline: March 4, 2027

Application Window Closes: March 4, 2027

Keywords

NIAMS

Clinical Trial

Implementation

Cooperative Agreement

UG3

UH3

Grant

Research Support

Biomedical

Health Sciences

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers